Jpmorgan Chase & CO Ptc Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 680,933 shares of PTCT stock, worth $27.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

680,933

Previous 617,386 10.29%

Holding current value

$27.5 Million

Previous $18 Million 15.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$24.69 - $40.12 $1.57 Million - $2.55 Million	63,547 Added 10.29%	680,933 $20.8 Million
Q1 2024 May 10, 2024	SELL	$24.15 - $31.95 $1.97 Million - $2.61 Million	-81,666 Reduced 11.68%	617,386 $18 Million
Q4 2023 Feb 12, 2024	SELL	$18.07 - $29.37 $3.32 Million - $5.39 Million	-183,500 Reduced 20.79%	699,052 $19.3 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $916,636 - $1.72 Million	-40,903 Reduced 4.43%	882,552 $19.8 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $2.22 Million - $3.25 Million	55,002 Added 6.33%	923,455 $37.6 Million
Q1 2023 May 18, 2023	BUY	$38.16 - $48.86 $3.4 Million - $4.35 Million	89,021 Added 11.42%	868,453 $42.1 Million
Q1 2023 May 11, 2023	SELL	$38.16 - $48.86 $3.14 Million - $4.02 Million	-82,338 Reduced 9.55%	779,432 $37.8 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $1.44 Million - $2.36 Million	43,051 Added 5.26%	861,770 $32.9 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $1.99 Million - $2.56 Million	-47,476 Reduced 5.48%	818,719 $41.1 Million
Q2 2022 Aug 11, 2022	BUY	$25.6 - $45.23 $1.96 Million - $3.46 Million	76,460 Added 9.68%	866,195 $34.7 Million
Q1 2022 May 11, 2022	BUY	$33.33 - $44.6 $5.28 Million - $7.06 Million	158,330 Added 25.08%	789,735 $29.5 Million
Q4 2021 Feb 10, 2022	BUY	$35.36 - $41.86 $1.32 Million - $1.56 Million	37,239 Added 6.27%	631,405 $25.1 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $22 Million - $26.6 Million	594,166 New	594,166 $22.1 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

79.3M

Call Options Held

122K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.89B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ptc Therapeutics, Inc. Transaction History